Regeneron Pharmaceuticals
REGN
#284
Rank
HK$487.38 B
Marketcap
HK$4,458
Share price
-6.09%
Change (1 day)
-39.23%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): HK$292.58

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$290.44. In 2022 the company made an earnings per share (EPS) of HK$315.01 a decrease over its 2021 EPS that were of HK$594.34.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$292.58-7.12%
2022HK$315.01-47%
2021HK$594.34133.36%
2020HK$254.6869.13%
2019HK$150.59-14.44%
2018HK$176.01100.71%
2017HK$87.6931.78%
2016HK$66.5538.96%
2015HK$47.8972.55%
2014HK$27.75-17.55%
2013HK$33.66-44.98%
2012HK$61.18-422.54%
2011-HK$18.9792.13%
2010-HK$9.8749.41%
2009-HK$6.61-15.84%
2008-HK$7.85-36.88%
2007-HK$12.44-9.6%
2006-HK$13.764.12%
2005-HK$13.22-323.68%
2004HK$5.91-135.51%
2003-HK$16.64-24.38%
2002-HK$22.0056.35%
2001-HK$14.07187.3%
2000-HK$4.90-16%
1999-HK$5.83177.78%
1998-HK$2.10-35.71%
1997-HK$3.27-68.42%
1996-HK$10.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$110.00-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.95-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.51-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.50-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.08-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$24.72-91.49%๐Ÿ‡ซ๐Ÿ‡ท France